PMPN_Pharmaceutical & Medical Packaging News

Pharmaceutical & Medical Packaging News, July/August 2015

Issue link: http://dc.cn.ubm-us.com/i/553643

Contents of this Issue

Navigation

Page 6 of 83

7 July/August 2015 Pharmaceutical & Medical Packaging News • pmpnews.com in new package development. Namely, "showing the value add to the busi- ness, ROI, NPV, getting operations to buy into the vision for a new packag- ing system and make the investment," says one professional in the Salary and Industry Outlook survey. In addition, they are working at "appeasing marketing while mak- ing the best decisions for cost, user friendliness, ease of manufacturing, and environmentally correct," says another respondent. Other challenges include "schedul- ing time on production lines to actu- ally run product qualification orders," says one professional. Says another: "Timing, getting a frozen design, fighting with management over what is the best solution for a short term project versus what packaging man- agement is looking to 'standardize.' Management being a [hindrance] and micromanaging your work." A n d y e t a n o t h e r r e s p o n d e n t describes this challenge: "Preventing a new platform from being tied to NPD project launch in order to pro- vide the timing required to develop the system properly." So, when striving to meet all regu- lations and launch deadlines, do pack- aging professionals even have time for innovation? "When packaging patented medi- cines, packagers don't want to get in the way of an approval or launch, so they focus on barrier, stability testing, etc. It is all about the molecule and its successful launch. Once launched, they don't want to put the supply chain at risk," said Peter Schmitt, managing director of Montesino Associates, who spoke earlier this year at Pharmapack Europe about trends during the North America Packaging Trends Network- ing Breakfast. As a result, he sees little focus on the patient/consumer outside of regulatory requirements. "The focus for child resistance and senior friendli- ness, for instance, is on meeting require- ments, rather than on innovation or diferentiation," he says. Also, the typical U.S. p h a r m a c e u t i c a l s u p p l y c h a i n h a s n ' t d e m a n d e d innovation, instead relying significantly on pharmacy repackaging for patients' p r e s c r i p t i o n s . A n d t h e growth of mail-order phar- macies has fostered demand for packaging efciency and standardization, I pointed out during the Pharmapack Europe breakfast. D e m a n d f o r p a c k a g e innovation may be material- izing, however. The Centers for Medicare and Medicaid Services is instituting patient outcome and experience measures, such as ratings for patient safety and medica- tion adherence, I pointed out. And more and more pharmacy retailers are look- ing for packaging that drives adherence and diferentiates their offerings while lower- ing supply-chain costs, added Schmitt. "There's an oppor- tunity for contract packagers/out- sourced suppliers to develop creative, even disruptive packaging," he said. What's next fOR phaRma? The notion of disruption in phar- maceutical packaging was examined during the conference at Pharmapack North America in June. During the June 9 panel discussion "What's Next for Pharma?" modera- tors Schmitt and Frank Bieganousky (also managing director of Montesino Asso- ciates) noted that FDA is increasingly interested in how patients are taking their medications. Self medication is more prevalent, and there's an interest in mak- ing administration easier for the patient and helping them with compliance. Before the discussion Schmitt mused whether packaging change would hap- pen through disruption rather than evo- lution, while Bieganousky wondered whether some pharmaceutical compa- nies might be turning to outsourcing and partnerships to increase their chances of developing an efective package. "So how will packaging get smart?" they asked panelists Siong Ho, senior director, pack- aging science & technology, Shire; Jim Powers, senior director of package engi- neering for Teva Pharmaceuticals; and Walter Berghahn, Executive Direc- tor, Healthcare Compliance Packaging Council. "There will be controlled dis- r u p t i v e c h a n g e , " s a i d P o w e r s . "There'll be evolution in packaging presentations." That evolution has already started. "Fifteen to 20 years ago, [the indus- try] was not primarily focused on how patients would use packaging," said Percentages of 499 respondents to the PMP News 2015 Market Segment Study on what motivates them to invest in new equipment, materials, and services. (Multiple answers allowed for this question and the other two cited in this story.) Why Are You Investing in New Equipment, Materials, and Services? ent, 54% 49% 46% 40% 34% 32% 29% 25% 22% 15% Increase manufacturing capacity Increase profitability Comply with FDA regulations Reduce waste/resource use Increase automation Upgrade packaging equipment Upgrade packaging materials Manage supply chain Compete in global marketplace Anticounterfeiting/brand protection Continued on page 10

Articles in this issue

Links on this page

Archives of this issue

view archives of PMPN_Pharmaceutical & Medical Packaging News - Pharmaceutical & Medical Packaging News, July/August 2015